Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
Abstract Background The development of personalized approaches in psoriatic arthritis (PsA) is challenging due to unclear patient phenotypes and trajectories. Machine learning (ML) could help to identify homogeneous patient groups. The objective of this analysis was to classify patients with PsA int...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-11-01
|
| Serier: | Arthritis Research & Therapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13075-025-03670-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
